Irinotecan in Treating Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1998

Primary Completion Date

March 31, 2001

Study Completion Date

March 31, 2001

Conditions
Colorectal Cancer
Interventions
DRUG

irinotecan hydrochloride

PROCEDURE

surgical procedure

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003544 - Irinotecan in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter